Showing results (181-190 of 407) with videos related to
Sort By:
Pageof 41
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 4, 2005
Aortic calcification in haemodialysis patients with diabetes mellitusHiromichi Taniwaki, Eiji Ishimura, Tsutomu Tabata, et al.Nephron. Clinical Practice|May 22, 2013
Nephronectin expression in glomeruli of renal biopsy specimens from various kidney diseases: nephronectin is expressed in the mesangial matrix expansion of diabetic nephropathyShinya Nakatani, Eiji Ishimura, Katsuhito Mori, et al.Clinical Calcium|November 11, 2005
[Significance of serum PTH (7-84) as a reliable nutritional marker in hemodialysis patients]Kaori Shidara, Masaaki Inaba, Yasuro Kumeda, et al.Scientific Reports|March 12, 2020
Association of plasma xanthine oxidoreductase activity with blood pressure affected by oxidative stress level: MedCity21 health examination registryShio Yoshida, Masafumi Kurajoh, Shinya Fukumoto, et al.Journal of Bone and Mineral Metabolism|January 4, 2020
Bazedoxifene improves renal function and increases renal phosphate excretion in patients with postmenopausal osteoporosisHideki Masaki, Yasuo Imanishi, Hiroshi Naka, et al.Minerva Endocrinologica|February 15, 2018
Association of heterogeneity of the thyroid gland with matrix metalloproteinase-3 in rheumatoid arthritis patients with Hashimoto's thyroiditisToshiki Nagasaki, Yuki Nagata, Yosuke Wakita, et al.Kidney & Blood Pressure Research|October 11, 2014
Significant association between bone-specific alkaline phosphatase and vascular calcification of the hand arteries in male hemodialysis patientsEiji Ishimura, Senji Okuno, Hisanori Okazaki, et al.Nephron. Clinical Practice|November 16, 2005
Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assayTakao Tsuchida, Eiji Ishimura, Kaname Hirowatari, et al.Case Reports in Nephrology and Dialysis|April 2, 2020
Long-Term Effects of High-Dose Tolvaptan for Autosomal Dominant Polycystic Kidney Disease PatientsShinya Nakatani, Eiji Ishimura, Yuri Machiba, et al.Journal of Atherosclerosis and Thrombosis|October 21, 2003
Arterial wall thickness is associated with insulin resistance in type 2 diabetic patientsShigehiko Fujiwara, Masanori Emoto, Miyoko Komatsu, et al.Pageof 41